CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-14 | Crombez Eric Director | Sale | −4,718 | $6.93 | $33K | 42,427 |
| 2025-07-22 | Vazzano Joseph Walter Chief Financial Officer | Sale | −1,502 | $6.64 | $10K | 477,666 |
| 2025-07-09 | Seshadri Vishwas Chief Executive Officer | Sale | −69,420 | $5.86 | $407K | 1,234,341 |
| 2025-07-09 | Silverstein Christine Berni Director | Sale | −13,093 | $5.86 | $77K | 120,479 |
| 2025-07-09 | Vazzano Joseph Walter Chief Financial Officer | Sale | −25,411 | $5.86 | $149K | 479,168 |
| 2025-07-09 | Charles Faith L. Director | Sale | −10,738 | $5.86 | $63K | 139,094 |
| 2025-07-09 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | −17,428 | $5.86 | $102K | 360,817 |
| 2025-07-09 | Alvino Mark Director | Sale | −13,093 | $5.86 | $77K | 77,252 |
| 2025-07-08 | Wuchterl Donald A. Director | Sale 10b5-1 | −5,176 | $5.82 | $30K | 145,436 |
| 2025-06-06 | Vazzano Joseph Walter Chief Financial Officer | Sale | −17,795 | $6.76 | $120K | 491,246 |
| 2025-06-06 | Seshadri Vishwas Chief Executive Officer | Sale | −50,676 | $6.76 | $343K | 1,303,761 |
| 2025-06-06 | O'Malley Brendan M. SVP, General Counsel | Sale | −10,470 | $6.76 | $71K | 378,245 |
| 2025-06-05 | Vazzano Joseph Walter Chief Financial Officer | Grant or award | +13,333 | 504,579 | ||
| 2025-06-01 | Seshadri Vishwas Chief Executive Officer | Shares withheld for taxes | −885 | $6.24 | $6K | 1,354,437 |
| 2025-05-27 | Alvino Mark Director | Sale | −2,000 | $6.38 | $13K | 90,435 |
| 2025-05-16 | Alvino Mark Director | Sale | −8,000 | $5.68 | $45K | 92,435 |
| 2025-03-31 | Seshadri Vishwas Chief Executive Officer | Sale 10b5-1 | −25,000 | $4.78 | $120K | 1,355,322 |
| 2025-03-14 | Vazzano Joseph Walter Chief Financial Officer | Shares withheld for taxes | −685 | $5.29 | $4K | 509,041 |
| 2025-03-03 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −181 | $5.24 | $948 | 388,715 |
| 2025-01-31 | Zeiher Bernhardt G Director | Grant or award | +36,101 | 47,145 |
Page 4 of 12 · 223 trades